{
  "docId": "019de073-cc15-73cb-b985-dc28972c4284",
  "docSlug": "df7f4367d54f16f4cdacd02ff486e30b",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 31 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 3,
  "pageCount": 31,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-cc15-73cb-b985-dc28972c4284/3",
  "deckHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284",
  "deckJsonHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284.json",
  "deckAnchorHref": "/decks/019de073-cc15-73cb-b985-dc28972c4284#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "image",
      "text": "Targeting icon",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0bdd7695-9823-475c-bea5-e612e6aa4f21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.75,
        "y": 0.25
      },
      "kind": "image",
      "text": "Versatility icon",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b52914e-73de-4ff6-a901-66758ea0a360",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "image",
      "text": "Safety icon",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6262bb6f-43ff-4f0a-bbc0-fded815b0eb9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "Extra-hepatic Targeting: Primary component (phosphatidylserine) facilitates preferential cellular uptake; Demonstrated uptake by phagocytes and cells with externalized PS; Enables targeted extra-hepatic delivery in infection, inflammation and oncology; Demonstrated delivery across the BBB",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e6ed6c5-dfa6-47f3-b4d3-df8aa6f1c2a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.38,
        "y": 0.55
      },
      "kind": "list",
      "text": "Safe: No evidence of immunogenicity; No cytotoxicity; Delivers high tissue concentrations of drug with low plasma levels; No off-target toxicity observed to date",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "575dab13-c4a1-4bbd-ae28-ef25b97c2200",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.7,
        "y": 0.55
      },
      "kind": "list",
      "text": "Versatile: Delivery of small molecules, proteins, nucleic acid polymers (ASOs, siRNA, DNA, mRNA), and vaccines - without membrane damage; Multiple routes of administration (including oral); Improved stability and shelf-life",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95d46d48-8c35-414a-95fe-c4472e6e7045",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.15
      },
      "kind": "title",
      "text": "Next generation delivery - beyond LNPs and viral vectors",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "839af6b2-7dca-4b96-a94a-6fd5c779c411",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Lipid Nanocrystal (LNC) Platform: Clinically Validated Intracellular Delivery",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31c01a3e-47f9-4c7e-b66d-d431de32a27e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "d689dfcc-abd4-4005-8f08-8a983ce7a762",
      "evidence": "title/action-title: Next generation delivery - beyond LNPs and viral vectors",
      "confidence": 0.8
    },
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "4069d488-3f16-452d-8cbe-e9b8e0a5b766",
      "evidence": "list/bullet: Extra-hepatic Targeting: Primary component (phosphatidylserine) facilitates preferential cellular uptake; Demonstrated uptake by phagocytes and cells with externalized PS; Enables targeted extra-hepatic deli",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}